Maneesh Dave
Maneesh Dave
Gastroenterology and Hepatology, University of California Davis
Verified email at
Cited by
Cited by
The human gut microbiome: current knowledge, challenges, and future directions
M Dave, PD Higgins, S Middha, KP Rioux
Translational Research 160 (4), 246-257, 2012
Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature
J Luther, M Dave, PDR Higgins, JY Kao
Inflammatory bowel diseases 16 (6), 1077-1084, 2010
Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography
M Dave, BJ Elmunzer, BA Dwamena, PDR Higgins
Radiology 256 (2), 387-396, 2010
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical …
L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ...
Endoscopy 49 (06), 588-608, 2017
Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability
J Luther, JJ Garber, H Khalili, M Dave, SS Bale, R Jindal, DL Motola, ...
Cellular and molecular gastroenterology and hepatology 1 (2), 222-232. e2, 2015
Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease
J Adler, DR Punglia, JR Dillman, AD Polydorides, M Dave, MM Al-Hawary, ...
Inflammatory bowel diseases 18 (5), 849-856, 2012
Mucosal healing in inflammatory bowel disease—a true paradigm of success?
M Dave, EV Loftus Jr
Gastroenterology & hepatology 8 (1), 29, 2012
Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease
AB Dietz, EJ Dozois, JG Fletcher, GW Butler, D Radel, AL Lightner, ...
Gastroenterology 153 (1), 59-62. e2, 2017
A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis
S Yadav, M Dave, JE Varayil, WS Harmsen, WJ Tremaine, AR Zinsmeister, ...
Clinical Gastroenterology and Hepatology 13 (4), 731-738. e6, 2015
Opportunistic infections due to inflammatory bowel disease therapy
M Dave, T Purohit, R Razonable, EV Loftus Jr
Inflammatory bowel diseases 20 (1), 196-212, 2014
Mesenchymal stem cell therapy for inflammatory bowel disease: a systematic review and meta-analysis
M Dave, K Mehta, J Luther, A Baruah, AB Dietz, WA Faubion Jr
Inflammatory bowel diseases 21 (11), 2696-2707, 2015
Immunology of inflammatory bowel disease and molecular targets for biologics
M Dave, KA Papadakis, WA Faubion
Gastroenterology Clinics 43 (3), 405-424, 2014
Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma
S Sethi, N Tageja, J Singh, H Arabi, M Dave, A Badheka, S Revankar
The American journal of the medical sciences 338 (6), 522, 2009
Understanding the cautions and contraindications of immunomodulator and biologic therapies for use in inflammatory bowel disease
HM Cohn, M Dave, EV Loftus Jr
Inflammatory bowel diseases 23 (8), 1301-1315, 2017
Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity
JC Joyce, AK Waljee, T Khan, PA Wren, M Dave, EM Zimmermann, ...
Health and Quality of Life Outcomes 6 (1), 1-12, 2008
Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene
Y Xiong, PA Svingen, OO Sarmento, TC Smyrk, M Dave, S Khanna, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2014
Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated TumorigenesisTWEAK/Fn14 Protects against Colitis-Associated Cancer
L Di Martino, M Dave, P Menghini, W Xin, KO Arseneau, TT Pizarro, ...
Cancer research 76 (22), 6533-6542, 2016
A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum
M Dave, LA Johnson, ST Walk, VB Young, RW Stidham, MN Chaudhary, ...
Gut 60 (8), 1043, 2011
Efficacy and safety of mesenchymal stem/stromal cell therapy for inflammatory bowel diseases: an up-to-date systematic review
JZH Ko, S Johnson, M Dave
Biomolecules 11 (1), 82, 2021
Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission
M Dave, P Jaiswal, F Cominelli
Current opinion in gastroenterology 33 (1), 59-68, 2017
The system can't perform the operation now. Try again later.
Articles 1–20